|
|
#1
08-02-2016, 04:52 PM
|
|||
|
|||
Shire upgrades Baxalta cost savings after Q2 earnings beat
LONDON, Aug 2 (Reuters) - Drugmaker Shire upgraded its guidance for 2016 on Tuesday, after it hiked the predicted cost saving target for its $32 billion acquisition of rare disease ***** specialist... ??????? ??????: Shire upgrades Baxalta cost savings after Q2 earnings beat || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
